Hamilton Lane Advisors LLC Karuna Therapeutics, Inc. Transaction History

Hamilton Lane Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jun 03, 2024	BUY	$176.32 - $240.22 $892,355 - $1.22 Million	5,061 New	5,061 $1.1 Million
Q2 2023 Aug 08, 2023	SELL	$176.32 - $240.22 $1.63 Million - $2.22 Million	-9,222 Reduced 64.57%	5,061 $1.1 Million
Q1 2023 May 28, 2024	BUY	$161.33 - $204.36 $2.3 Million - $2.92 Million	14,283 New	14,283 $2.59 Million
Q1 2023 May 02, 2023	SELL	$161.33 - $204.36 $8.04 Million - $10.2 Million	-49,807 Reduced 77.71%	14,283 $2.59 Million
Q4 2022 Feb 09, 2023	SELL	$191.53 - $236.82 $2.53 Million - $3.13 Million	-13,196 Reduced 17.07%	64,090 $12.6 Million
Q3 2022 Nov 08, 2022	BUY	$123.79 - $277.42 $9.57 Million - $21.4 Million	77,286 New	77,286 $17.4 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.